X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (10) 10
humans (10) 10
male (10) 10
middle aged (10) 10
aged (8) 8
gastroenterology & hepatology (8) 8
adult (7) 7
helicobacter infections - drug therapy (7) 7
drug therapy, combination (6) 6
helicobacter pylori (6) 6
amoxicillin (4) 4
amoxicillin - therapeutic use (4) 4
double-blind method (4) 4
eradication (4) 4
helicobacter infections - microbiology (4) 4
helicobacter pylori - drug effects (4) 4
recurrence (4) 4
treatment outcome (4) 4
administration, oral (3) 3
amoxicillin - administration & dosage (3) 3
anti-bacterial agents - therapeutic use (3) 3
anti-inflammatory agents - administration & dosage (3) 3
anti-ulcer agents - therapeutic use (3) 3
bismuth - therapeutic use (3) 3
clarithromycin (3) 3
clarithromycin - pharmacology (3) 3
duodenal ulcer - drug therapy (3) 3
duodenal-ulcer (3) 3
follow-up studies (3) 3
infection (3) 3
lymphocytic colitis (3) 3
metronidazole (3) 3
metronidazole - pharmacology (3) 3
microbiology (3) 3
omeprazole (3) 3
omeprazole - therapeutic use (3) 3
organometallic compounds - therapeutic use (3) 3
penicillins - therapeutic use (3) 3
time factors (3) 3
triple therapy (3) 3
active crohns-disease (2) 2
adolescent (2) 2
anti-inflammatory agents - adverse effects (2) 2
anti-inflammatory agents - therapeutic use (2) 2
antimicrobial resistance (2) 2
bismuth - administration & dosage (2) 2
budesonide - administration & dosage (2) 2
campylobacter-pylori (2) 2
colitis, collagenous - complications (2) 2
colitis, collagenous - drug therapy (2) 2
collagenous colitis (2) 2
colonization (2) 2
disease (2) 2
dose-response relationship, drug (2) 2
drug administration schedule (2) 2
drug resistance, bacterial (2) 2
duodenal ulcer - microbiology (2) 2
esomeprazole (2) 2
esomeprazole - therapeutic use (2) 2
gastric mucosa - microbiology (2) 2
gastric mucosa - pathology (2) 2
germany (2) 2
h. pylori (2) 2
helicobacter pylori - isolation & purification (2) 2
levofloxacin (2) 2
metronidazole resistance (2) 2
microbial sensitivity tests (2) 2
omeprazole - administration & dosage (2) 2
organometallic compounds - administration & dosage (2) 2
placebos (2) 2
prospective studies (2) 2
quadruple therapy (2) 2
quality of life (2) 2
randomized-trial (2) 2
relapse (2) 2
resistance (2) 2
salicylates - therapeutic use (2) 2
stomach ulcer - microbiology (2) 2
surgery (2) 2
therapy (2) 2
tinidazole - therapeutic use (2) 2
1st-line treatment (1) 1
2nd-line therapies (1) 1
2nd-line treatment (1) 1
5-lipoxygenase inhibition (1) 1
acetyl-11-keto-beta-boswellic acid (1) 1
acid control (1) 1
agar dilution (1) 1
aged, 80 and over (1) 1
amoxicillin - adverse effects (1) 1
amoxycillin (1) 1
anti-bacterial agents - administration & dosage (1) 1
anti-bacterial agents - adverse effects (1) 1
anti-bacterial agents - pharmacology (1) 1
anti-ulcer agents - administration & dosage (1) 1
aryl hydrocarbon hydroxylases - genetics (1) 1
aza compounds - administration & dosage (1) 1
aza compounds - therapeutic use (1) 1
biopsy (1) 1
bismuth subsalicylate (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Colorectal Disease, ISSN 0179-1958, 12/2007, Volume 22, Issue 12, pp. 1445 - 1451
Journal Article
Helicobacter, ISSN 1083-4389, 02/2006, Volume 11, Issue 1, pp. 39 - 45
Journal Article
Journal Article
Helicobacter, ISSN 1083-4389, 08/2003, Volume 8, Issue 4, pp. 310 - 319
ABSTRACT Background and Aim. Failure of primary anti‐H. pylori therapy results in a high rate of antimicrobial resistance. Here, we investigated the efficacy... 
amoxicillin | omeprazole | dual therapy | metronidazole | Antimicrobial resistance | clarithromycin | quadruple therapy | Omeprazole | Clarithromycin | Amoxicillin | Dual therapy | Metronidazole | Quadruple therapy | AGAR DILUTION | CURE RATES | MICROBIOLOGY | PRETREATMENT ANTIBIOTIC-RESISTANCE | CONSENSUS-CONFERENCE | antimicrobial resistance | PROTON PUMP INHIBITOR | H. PYLORI | TRIPLE THERAPY | INFECTION | ERADICATION | GASTROENTEROLOGY & HEPATOLOGY | Bismuth - administration & dosage | Gastric Mucosa - microbiology | Humans | Middle Aged | Helicobacter pylori - genetics | Gastric Mucosa - pathology | Helicobacter pylori - drug effects | Male | Urea - analysis | Bismuth - therapeutic use | Anti-Bacterial Agents - therapeutic use | Metronidazole - therapeutic use | Drug Resistance, Multiple, Bacterial | Helicobacter Infections - drug therapy | Organometallic Compounds - therapeutic use | Adult | Female | Amoxicillin - administration & dosage | Drug Therapy, Combination | Anti-Ulcer Agents - therapeutic use | Omeprazole - therapeutic use | Penicillins - therapeutic use | Metronidazole - administration & dosage | Omeprazole - administration & dosage | Tetracycline - therapeutic use | Anti-Ulcer Agents - administration & dosage | Metronidazole - pharmacology | Amoxicillin - therapeutic use | Aged | Anti-Bacterial Agents - administration & dosage | Clarithromycin - pharmacology | Tetracycline - administration & dosage | Helicobacter Infections - microbiology | Organometallic Compounds - administration & dosage
Journal Article
Helicobacter, ISSN 1083-4389, 02/2008, Volume 13, Issue 1, pp. 69 - 74
Aim:  To investigate a 1‐week once‐daily triple therapy with esomeprazole, moxifloxacin, and rifabutin for rescue therapy of Helicobacter pylori infection.... 
esomeprazole | CYP2C19 polymorphism | Helicobacter pylori | levofloxacin | rifabutin | metronidazole | fluoroquinolones | clarithromycin | resistance | moxifloxacin | Fluoroquinolones | Resistance | Rifabutin | Levofloxacin | Clarithromycin | Esomeprazole | Metronidazole | Moxifloxacin | 1ST-LINE TREATMENT | METAANALYSIS | RANDOMIZED-TRIAL | MICROBIOLOGY | PREVALENCE | DOSE DUAL THERAPY | QUADRUPLE THERAPY | 2ND-LINE TREATMENT | INFECTION | GASTROENTEROLOGY & HEPATOLOGY | TREATMENT FAILURE | Prospective Studies | Esomeprazole - administration & dosage | Aza Compounds - therapeutic use | Humans | Middle Aged | Aryl Hydrocarbon Hydroxylases - genetics | Drug Resistance, Bacterial | Gastric Mucosa - pathology | Helicobacter pylori - drug effects | Male | Rifabutin - administration & dosage | Quinolines - administration & dosage | Esomeprazole - therapeutic use | Anti-Bacterial Agents - therapeutic use | Helicobacter Infections - drug therapy | Adult | Female | Drug Therapy, Combination | Aza Compounds - administration & dosage | Metronidazole - pharmacology | Polymorphism, Restriction Fragment Length | Cytochrome P-450 CYP2C19 | Rifabutin - therapeutic use | Aged | Anti-Bacterial Agents - pharmacology | Helicobacter pylori - isolation & purification | Quinolines - therapeutic use | Mixed Function Oxygenases - genetics | Clarithromycin - pharmacology | Helicobacter Infections - microbiology | Proton pump inhibitors | Polyketides | Corticosteroids
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 09/2003, Volume 98, Issue s9, pp. S261 - S262
Journal Article
DMW - Deutsche Medizinische Wochenschrift, ISSN 0012-0472, 05/2011, Volume 136, Issue 18, pp. 939 - 943
Zusammenfassung HINTERGRUND: Im September 2009 empfahl die Ständige Impfkommission (STIKO) die Impfung von Patienten mit chronischen Erkrankungen gegen die... 
Originalarbeit | Original article | Crohn's disease | ulcerative colitis | H1N1 | swine flu | vaccination
Journal Article
Journal Article
Journal Article
European Journal of Gastroenterology & Hepatology, ISSN 0954-691X, 04/1996, Volume 8, Issue 4, pp. 343 - 350
Journal Article
The American Journal of Gastroenterology, ISSN 0002-9270, 2003, Volume 98, Issue 9, pp. S261 - S262
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.